特朗普政府宣布，联邦医疗补助计划（Medicaid）和儿童健康保险计划（CHIP）将停止为变性未成年人支付性别认同相关手术和激素治疗费用[1]。新政策自10月13日起生效，其中激素治疗的覆盖将在2027年4月前逐步停止[1]。根据该政策，心理健康治疗仍可继续获得联邦资助[1]。特朗普在社交媒体上表示："我们不会为我们无辜的孩子支付这些野蛮的手术和做法，这些做法对他们年幼的身体造成难以置信且不可逆转的伤害"[1]。
这项决定面临医学界的反对。美国医学会等主要医学组织支持患者获取性别认同相关医疗[1]。人权运动组织主席凯莉·罗宾逊表示将对该政策进行法律挑战[1]。此前，至少27个州已禁止为18岁以下者提供性别认同医疗[1]。
The Trump administration has announced that Medicaid and the Children's Health Insurance Program (CHIP) will cease funding gender-affirming surgeries and hormone treatments for transgender minors.[1] The policy takes effect on October 13.[1] While mental health treatment coverage will continue, hormone therapy coverage will be phased out by April 2027.[1]
Under the new directive, CHIP will no longer pay for gender-affirming medical services for patients under 19 years old.[1] President Trump stated on social media: "We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies."[1] This action represents the latest in a series of policy measures targeting transgender individuals since the Trump administration took office.[1]
The decision faces significant opposition from medical professionals and advocacy groups. Major medical organizations including the American Medical Association support access to gender-affirming care,[1] and the Human Rights Campaign's president, Kelly Robinson, has indicated plans to mount legal challenges.[1] At least 27 states have already banned gender-affirming medical care for those under 18 years old.[1]